Figure 3.
Hazard ratios and 95% confidence intervals of the PLT counts (low vs. moderate; high vs. moderate; high vs. low) for (A) overall survival (OS) rates in the CCRT patients; (B) distant metastasis-free survival (DMFS) rates in the CCRT patients; (C) OS rates in the RT patients; and (D) DMFS rates in the RT patients. CCRT, concurrent chemoradiotherapy; PLT, platelet; RT, radiotherapy alone.